Telix Pharmaceuticals Limited (ASX:TLX)

Telix Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 30, 2026	Dec 31, 2025	Dec 31, 2024	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021
Market Capitalization	4,629	3,794	8,238	3,263	2,300	2,209
Market Cap Growth	-49.40%	-53.94%	152.44%	41.89%	4.10%	108.44%
Enterprise Value	5,117	4,116	8,141	3,145	2,180	2,161
Last Close Price	13.66	11.20	24.61	10.08	7.27	7.75
PE Ratio	-	-	151.34	528.32	-	-
Forward PE	-	282.12	87.27	32.83	-	-
PS Ratio	3.84	3.15	9.87	6.68	14.37	290.85
PB Ratio	7.43	6.09	14.44	21.66	28.75	1023.78
P/TBV Ratio	-	-	53.62	80.58	109.40	-
P/FCF Ratio	-	-	277.46	279.08	-	-
P/OCF Ratio	-	-	185.44	155.76	-	-
EV/Sales Ratio	4.25	3.42	9.75	6.43	13.62	284.54
EV/EBITDA Ratio	84.83	84.58	84.48	56.13	-	-
EV/EBIT Ratio	176.96	142.35	90.15	61.25	-	-
EV/FCF Ratio	-79.40	-	274.21	268.94	-	-
Debt / Equity Ratio	1.13	1.13	1.02	0.12	0.13	1.18
Debt / EBITDA Ratio	11.61	11.61	5.89	0.31	-	-
Debt / FCF Ratio	-	-	19.60	1.54	-	-
Net Debt / Equity Ratio	0.78	0.78	-0.23	-0.70	-1.32	-9.03
Net Debt / EBITDA Ratio	10.02	10.02	-1.34	-1.89	1.52	0.25
Net Debt / FCF Ratio	-7.57	-7.57	-4.34	-9.04	1.49	0.32
Asset Turnover	0.76	0.76	0.85	1.48	0.88	0.06
Inventory Turnover	13.90	13.90	10.84	14.01	10.92	1.25
Quick Ratio	1.21	1.21	2.63	1.20	1.90	1.13
Current Ratio	1.43	1.43	2.78	1.43	2.03	1.25
Return on Equity (ROE)	-1.85%	-1.85%	14.79%	5.36%	-253.34%	-198.36%
Return on Assets (ROA)	1.15%	1.15%	5.74%	9.69%	-25.37%	-37.95%
Return on Invested Capital (ROIC)	2.60%	3.81%	32.69%	537.03%	-	-
Return on Capital Employed (ROCE)	2.10%	2.10%	7.60%	21.10%	-43.60%	-113.10%
Earnings Yield	-0.23%	-0.28%	0.66%	0.19%	-4.53%	-3.64%
FCF Yield	-1.39%	-1.70%	0.36%	0.36%	-3.09%	-2.75%
Buyback Yield / Dilution	2.12%	2.12%	-6.64%	-4.21%	-10.08%	-9.69%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.